- Home
- BHC vs SGRY Comparison
BHC vs SGRY Comparison
Compare BHC & SGRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHC
- SGRY
- Stock Information
- Founded
- BHC N/A
- SGRY 2004
- Country
- BHC Canada
- SGRY United States
- Employees
- BHC N/A
- SGRY N/A
- Industry
- BHC Biotechnology: Pharmaceutical Preparations
- SGRY Hospital/Nursing Management
- Sector
- BHC Health Care
- SGRY Health Care
- Exchange
- BHC Nasdaq
- SGRY Nasdaq
- Market Cap
- BHC 3.0B
- SGRY 2.7B
- IPO Year
- BHC N/A
- SGRY 2015
- Fundamental
- Price
- BHC $7.47
- SGRY $20.51
- Analyst Decision
- BHC Hold
- SGRY Buy
- Analyst Count
- BHC 4
- SGRY 9
- Target Price
- BHC $7.25
- SGRY $37.38
- AVG Volume (30 Days)
- BHC 1.5M
- SGRY 857.9K
- Earning Date
- BHC 02-20-2025
- SGRY 02-24-2025
- Dividend Yield
- BHC N/A
- SGRY N/A
- EPS Growth
- BHC N/A
- SGRY N/A
- EPS
- BHC N/A
- SGRY N/A
- Revenue
- BHC $9,474,000,000.00
- SGRY $2,985,300,000.00
- Revenue This Year
- BHC $10.68
- SGRY $14.46
- Revenue Next Year
- BHC $3.66
- SGRY $9.94
- P/E Ratio
- BHC N/A
- SGRY N/A
- Revenue Growth
- BHC 10.91
- SGRY 9.96
- 52 Week Low
- BHC $3.96
- SGRY $19.50
- 52 Week High
- BHC $11.46
- SGRY $35.30
- Technical
- Relative Strength Index (RSI)
- BHC 42.13
- SGRY 44.60
- Support Level
- BHC $7.30
- SGRY $19.80
- Resistance Level
- BHC $8.03
- SGRY $21.41
- Average True Range (ATR)
- BHC 0.27
- SGRY 0.81
- MACD
- BHC -0.01
- SGRY 0.11
- Stochastic Oscillator
- BHC 17.35
- SGRY 31.33
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
About SGRY Surgery Partners Inc.
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.